Kyverna Therapeutics, Inc. (KYTX): SCHEDULE 13G/A filed Feb 17, 2026

Form type

SCHEDULE 13G/A

Filing date

Feb 17, 2026

Accession number

0001193125-26-054806

Filer

Kyverna Therapeutics, Inc. (CIK 1994702)